Monoclonal Antibodies for COVID-19 Treatment: Is It an Option in Indonesia?
More than three years after Coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV2), was declared pandemic by World Health Organization, report of COVID-19 hospitalization and death have been decreasing. Even though COVID-1...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2023-07-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | https://actamedindones.org/index.php/ijim/article/view/2582 |